Basilea Pharmaceutica (original) (raw)

dbo:abstract

Die Basilea Pharmaceutica AG ist ein biopharmazeutisches Unternehmen mit Sitz in Basel, Schweiz. Sie wurde im Jahr 2000 aus der F. Hoffmann-La Roche ausgegründet und ist seit März 2004 als eigenständiges Unternehmen an der Schweizer Börse kotiert. Ihre Marktkapitalisierung lag per Ende Februar 2018 bei knapp 822 Millionen Schweizer Franken. (de)
Basilea Pharmaceutica is a multinational specialty biopharmaceutical company headquartered in Basel, Switzerland. It was formed as a spin-off entity from the drug giant Hoffmann–La Roche in October 2000. It is engaged in the development of antibiotics, antifungals and oncology drugs for treatment of invasive aspergillosis and invasive mucormycosis. Basilea is publicly traded on the SIX Swiss exchange (SIX: BSLIN). The company is based in Basel, Switzerland. It has subsidiaries in France, Germany, Denmark, the People's Republic of China, Spain, the United Kingdom, and the United States of America. According to stock filings, it had 196 employees as of June 2007. Among the company's notable products is Isavuconazole (CRESEMBA), an intravenous and oral antifungal, which received orphan drug status designation by the United States Food and Drug Administration (FDA) in 2013. The company also manufactures pharmaceuticals for use against methicillin-resistant Staphylococcus aureus. (en)

dbo:foundingYear

2000-01-01 (xsd:gYear)

dbo:industry

dbr:Pharmaceuticals

dbo:keyPerson

dbr:CEO

dbo:numberOfEmployees

225 (xsd:nonNegativeInteger)

dbo:product

dbo:revenue

1.344E8 (dbd:swissFranc)

dbo:thumbnail

wiki-commons:Special:FilePath/Logo_Basilea.svg?width=300

dbo:type

dbr:Public_company

dbo:wikiPageExternalLink

http://www.basilea.com/

dbo:wikiPageID

13549119 (xsd:integer)

dbo:wikiPageLength

10749 (xsd:nonNegativeInteger)

dbo:wikiPageRevisionID

1032038660 (xsd:integer)

dbo:wikiPageWikiLink

dbp:foundation

2000 (xsd:integer)

dbp:homepage

http://www.basilea.com/

dbp:industry

dbr:Pharmaceuticals

dbp:keyPeople

David Veitch, (en)
Domenico Scala (en)

dbp:locationCity

dbr:Basel

dbp:locationCountry

dbr:Switzerland

dbp:logo

Logo Basilea.svg (en)

dbp:name

Basilea Pharmaceutica AG (en)

dbp:numEmployees

225 (xsd:integer)

dbp:products

dbp:revenue

1.344E8 (dbd:swissFranc)

dbp:type

Public (en)

dbp:wikiPageUsesTemplate

dbp:wordnet_type

http://www.w3.org/2006/03/wn/wn20/instances/synset-company-noun-1

dct:subject

gold:hypernym

dbr:Company

schema:sameAs

http://viaf.org/viaf/184145858179823022538

rdf:type

rdfs:comment

Die Basilea Pharmaceutica AG ist ein biopharmazeutisches Unternehmen mit Sitz in Basel, Schweiz. Sie wurde im Jahr 2000 aus der F. Hoffmann-La Roche ausgegründet und ist seit März 2004 als eigenständiges Unternehmen an der Schweizer Börse kotiert. Ihre Marktkapitalisierung lag per Ende Februar 2018 bei knapp 822 Millionen Schweizer Franken. (de)
Basilea Pharmaceutica is a multinational specialty biopharmaceutical company headquartered in Basel, Switzerland. It was formed as a spin-off entity from the drug giant Hoffmann–La Roche in October 2000. It is engaged in the development of antibiotics, antifungals and oncology drugs for treatment of invasive aspergillosis and invasive mucormycosis. Basilea is publicly traded on the SIX Swiss exchange (SIX: BSLIN). (en)

rdfs:label

Basilea Pharmaceutica (de)
Basilea Pharmaceutica (en)

owl:sameAs

skos:closeMatch

http://www.grid.ac/institutes/grid.418234.8

prov:wasDerivedFrom

wikipedia-en:Basilea_Pharmaceutica?oldid=1032038660&ns=0

foaf:depiction

foaf:homepage

http://www.basilea.com/

foaf:isPrimaryTopicOf

wikipedia-en:Basilea_Pharmaceutica

foaf:name

(en)
Basilea Pharmaceutica AG (en)

is dbo:wikiPageDisambiguates of

dbr:Basilea_(disambiguation)

is dbo:wikiPageWikiLink of

is foaf:primaryTopic of

wikipedia-en:Basilea_Pharmaceutica